B
L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S.,
“Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”,
Cytokine, vol. 2, no. 4, pp. 287-93, 1990.
L. E. Bermudez, Petrofsky, M., and Stevens, P.,
“Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”,
Immunology, vol. 94, no. 3, pp. 297-303, 1998.
L. E. Bermudez, Covaro, G., and Remington, J.,
“Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.”,
Infection and immunity, vol. 61, no. 10, pp. 4126-30, 1993.
L. E. Bermudez and Young, L. S.,
“Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.”,
Journal of immunology (Baltimore, Md. : 1950), vol. 140, no. 9, pp. 3006-13, 1988.
L. E. Bermudez, Panza, M., Velasco, E., and Vidal, E.,
“[Effect of systemic antibiotic therapy on microbial flora of gastrointestinal tract in the hematological patients].”,
Revista paulista de medicina, vol. 102, no. 6, pp. 256-9, 1984.
L. E. Bermudez, Inderlied, C., and Young, L. S.,
“Stimulation with cytokines enhances penetration of azithromycin into human macrophages.”,
Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B.,
“Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez, Danelishvili, L., and Early, J.,
“Mycobacteria and Macrophage Apoptosis: Complex Struggle for Survival.”,
Microbe Wash DC, vol. 1, no. 8, pp. 372-375, 2006.
L. E. Bermudez and Martins, C. A.,
“[Non-traumatic Clostridium infections].”,
AMB : revista da Associação Médica Brasileira, vol. 33, no. 1-2, pp. 38-9, 1987.
L. E. Bermudez, Wu, M., Martinelli, J., and Young, L. S.,
“Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages.”,
Lymphokine and cytokine research, vol. 10, no. 5, pp. 413-9, 1991.
L. E. Bermudez, Yau-Young, A. O., Lin, J. P., Cogger, J., and Young, L. S.,
“Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.”,
The Journal of infectious diseases, vol. 161, no. 6, pp. 1262-8, 1990.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S.,
“Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice.”,
The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.
L. E. Bermudez, Young, L. S., Martinelli, J., and Petrofsky, M.,
“Exposure to ethanol up-regulates the expression of Mycobacterium avium complex proteins associated with bacterial virulence.”,
The Journal of infectious diseases, vol. 168, no. 4, pp. 961-8, 1993.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S.,
“Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”,
Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.
L. E. Bermudez, Stevens, P., Kolonoski, P., Wu, M., and Young, L. S.,
“Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor.”,
Journal of immunology (Baltimore, Md. : 1950), vol. 143, no. 9, pp. 2996-3000, 1989.
L. E. Bermudez, Petrofsky, M., and Shelton, K.,
“Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection.”,
Infection and immunity, vol. 64, no. 8, pp. 2917-22, 1996.
L. E. Bermudez, Petrofsky, M., and Sangari, F.,
“Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype.”,
Cell biology international, vol. 28, no. 5, pp. 411-9, 2004.
L. E. Bermudez, Danelishvili, L., Babrack, L., and Pham, T.,
“Evidence for genes associated with the ability of Mycobacterium avium subsp. hominissuis to escape apoptotic macrophages.”,
Front Cell Infect Microbiol, vol. 5, p. 63, 2015.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B.,
“Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”,
The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.